REVOLUTION MEDICINES INC (1RVMD.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1RVMD - US76155X1000 - Common Stock
1RVMD.MI Key Statistics, Chart & Performance
The current stock price of 1RVMD.MI is 83 EUR.
1RVMD.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1RVMD.MI.
1RVMD.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1RVMD.MI. 1RVMD.MI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
1RVMD.MI Financial Highlights
Over the last trailing twelve months 1RVMD.MI reported a non-GAAP Earnings per Share(EPS) of -4.4. The EPS decreased by -44.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.65% | ||
| ROE | -37.58% | ||
| Debt/Equity | 0.16 |
1RVMD.MI Forecast & Estimates
27 analysts have analysed 1RVMD.MI and the average price target is 76.84 EUR. This implies a price decrease of -7.42% is expected in the next year compared to the current price of 83.
For the next year, analysts expect an EPS growth of -59.96% and a revenue growth 1279.08% for 1RVMD.MI
1RVMD.MI Ownership
About 1RVMD.MI
Company Profile
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 809 full-time employees. The company went IPO on 2020-02-13. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).
Company Info
REVOLUTION MEDICINES INC
700 Saginaw Dr
Redwood City CALIFORNIA US
Employees: 534
Phone: 16504816801
REVOLUTION MEDICINES INC / 1RVMD.MI FAQ
What does REVOLUTION MEDICINES INC do?
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 809 full-time employees. The company went IPO on 2020-02-13. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).
What is the current price of 1RVMD stock?
The current stock price of 1RVMD.MI is 83 EUR. The price increased by 25.76% in the last trading session.
What is the dividend status of REVOLUTION MEDICINES INC?
1RVMD.MI does not pay a dividend.
What is the ChartMill rating of REVOLUTION MEDICINES INC stock?
1RVMD.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What sector and industry does REVOLUTION MEDICINES INC belong to?
REVOLUTION MEDICINES INC (1RVMD.MI) operates in the Health Care sector and the Biotechnology industry.